Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis
NCT06775340 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 252
Last updated 2025-05-13
Summary
Studies to evaluate the safety, tolerability, pharmacodynamics, and efficacy of RSS0343 tablets in patients with non-cystic fibrosis bronchiectasis
Conditions
- Adolescent Asthma
Interventions
- DRUG
-
RSS0343 Tabella
RSS0343 tablets, oral;
Sponsors & Collaborators
-
Jiangsu HengRui Medicine Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-22
- Primary Completion
- 2027-11-30
- Completion
- 2027-12-31
Countries
- China
Study Locations
More Related Trials
-
Fractional Concentration of Exhaled NO(FENO) to Direct Montelukast Treatment of Sub-acute Cough
NCT02303600 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetics, Pharmacodynamics, Safety, and Preliminary Efficacy of Subcutaneous Injection of SHR-1905 in Adolescent Asthmatic Subjects - an Open-label, Single-dose Phase II Clinical Study
NCT06786455 ·Status: COMPLETED ·Phase: PHASE2
-
Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma
NCT02360072 ·Status: COMPLETED
-
Single Dose Study of GSK1440115 in Patients With Asthma
NCT01424280 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
NCT01269437 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Onset of Relief From Methacholine-induced Bronchoconstriction With CHF1535 NEXThaler in Asthmatic Patients.
NCT03108534 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients
NCT00660114 ·Status: COMPLETED
-
XC8 in the Treatment of Patients With Bronchial Asthma
NCT03450434 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.
NCT00603746 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Effect of Different Treatment Course With Inhaled Corticosteroids in Eosinophilic Bronchitis Patients
NCT02002715 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma
NCT05018299 ·Status: RECRUITING ·Phase: PHASE2
-
Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma
NCT01687296 ·Status: COMPLETED ·Phase: PHASE3
-
AMG 853 Phase 2 Study in Subjects With Inadequately Controlled Asthma
NCT01018550 ·Status: COMPLETED ·Phase: PHASE2
-
Fractional Concentration of Exhaled NO(FeNO) to Direct The Treatment of Sub-acute Cough
NCT02655562 ·Status: SUSPENDED ·Phase: PHASE4
-
Study of CM512 Injection in Subjects With Moderate-to-severe Asthma
NCT07011524 ·Status: RECRUITING ·Phase: PHASE2
-
Bronchodilator Response in 4-12 Years Chinese Controller Naive Asthmatic Children
NCT01500525 ·Status: COMPLETED
-
The Effect of MK0633 in Patients With Chronic Asthma (0633-007)
NCT00404313 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety Study of 610 in Patients With Severe Asthma
NCT06323213 ·Status: RECRUITING ·Phase: PHASE3
-
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Study in Healthy Subjects
NCT04772365 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.
NCT00603382 ·Status: COMPLETED ·Phase: PHASE2
-
Children-Adult Asthma Cohort Study in China
NCT03046433 ·Status: UNKNOWN
-
Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma
NCT00843193 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma.
NCT05472324 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
NCT06977581 ·Status: RECRUITING ·Phase: PHASE2
-
The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in China
NCT02143739 ·Status: COMPLETED